You may be interested in the following article which only showed an association between stroke and LVEF when LVEF was < 15%. I'm not 100% sure, but I don't think many participants in the DREAM-HF trial, if any, met this criteria. I expect Mesoblast would also be required to adjust their trial results for any confounding variables, including ejection fraction, when presenting their results to the FDA.
Title: Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure
https://www.ahajournals.org/doi/10.1161/STROKEAHA.116.013679
You may be interested in the following article which only showed...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
0.010(0.66%) |
Mkt cap ! $1.741B | |||
| Open | High | Low | Value | Volume |
| $1.50 | $1.54 | $1.48 | $5.605M | 3.713M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 55197 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.53 | 29782 | 3 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |